CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 2,810 shares at $21.37 ($60K) on 2016-12-14, disclosed to the SEC on 2016-12-16.
Open-market purchase of $60k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |